What is it about?
Lymphopenia and immune dysfunction in COVID-19 is increasingly recognized and studied. This case report details a secondary infection following lymphopenia with CD4+ count drop in a COVID-19 patient with no history of immunosuppression or infection with HIV. The mechanism of lymphopenia, both CD4+ and CD8+ T cell count drops, in COVID-19 needs further study.
Featured Image
Photo by CDC on Unsplash
Why is it important?
The literature has shown that COVID-19 patients commonly have lymphopenia, a decrease in CD4+ and/or CD8+ T cells, that may increase susceptibility to secondary bacterial infection. Here, we report a secondary pneumonia in a non-HIV COVID-19 patient with new CD4+ T cell depletion.
Perspectives
Read the Original
This page is a summary of: COVID-19 induced immunosuppression leading to secondary infection in a non-HIV patient, Minerva Respiratory Medicine, May 2021, Edizioni Minerva Medica,
DOI: 10.23736/s2784-8477.21.01914-3.
You can read the full text:
Resources
Contributors
The following have contributed to this page